BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28813246)

  • 21. An opportunity for clinical pharmacology trained physicians to improve patient drug safety: A retrospective analysis of adverse drug reactions in teenagers.
    Eugene AR; Eugene B
    F1000Res; 2018; 7():677. PubMed ID: 30271581
    [No Abstract]   [Full Text] [Related]  

  • 22. Miscategorization of Deaths in the US Food and Drug Administration Adverse Events Database.
    Meier L; Wang EY; Tomes M; Redberg RF
    JAMA Intern Med; 2020 Jan; 180(1):147-148. PubMed ID: 31589249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database.
    Fujimoto M; Higuchi T; Hosomi K; Takada M
    Int J Med Sci; 2015; 12(3):223-33. PubMed ID: 25678839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing Different Adverse Effects Among Multiple Drugs Using FAERS Data.
    Huang J; Zhang X; Du J; Duan R; Yang L; Moore JH; Chen Y; Tao C
    Stud Health Technol Inform; 2017; 245():1268. PubMed ID: 29295353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mini-Sentinel and regulatory science--big data rendered fit and functional.
    Psaty BM; Breckenridge AM
    N Engl J Med; 2014 Jun; 370(23):2165-7. PubMed ID: 24897081
    [No Abstract]   [Full Text] [Related]  

  • 26. Automatic detection of adverse events to predict drug label changes using text and data mining techniques.
    Gurulingappa H; Toldo L; Rajput AM; Kors JA; Taweel A; Tayrouz Y
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1189-94. PubMed ID: 23935003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between Benzodiazepine Use and Dementia: Data Mining of Different Medical Databases.
    Takada M; Fujimoto M; Hosomi K
    Int J Med Sci; 2016; 13(11):825-834. PubMed ID: 27877074
    [No Abstract]   [Full Text] [Related]  

  • 28. Mining Drugs and Indications for Suicide-Related Adverse Events.
    Ding T; Chen ES
    AMIA Annu Symp Proc; 2019; 2019():1011-1020. PubMed ID: 32308898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Filing Sources after Oral P2Y12 Platelet Inhibitors to the Food and Drug Administration Adverse Event Reporting System (FAERS).
    Serebruany VL; Cherepanov V; Kim MH; Litvinov O; Cabrera-Fuentes HA; Marciniak TA
    Cardiology; 2017; 138(4):249-253. PubMed ID: 28898876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases].
    Sasaoka S; Matsui T; Abe J; Umetsu R; Kato Y; Ueda N; Hane Y; Motooka Y; Hatahira H; Kinosada Y; Nakamura M
    Yakugaku Zasshi; 2016; 136(3):507-15. PubMed ID: 26935094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scientists mine web search data to identify epidemics and adverse events.
    Kuehn BM
    JAMA; 2013 May; 309(18):1883-4. PubMed ID: 23652502
    [No Abstract]   [Full Text] [Related]  

  • 32. More eyeballs on AERS.
    Pratt LA; Danese PN
    Nat Biotechnol; 2009 Jul; 27(7):601-2. PubMed ID: 19587659
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA turns to electronic "sentinel" to flag prescription drug safety problems.
    Kuehn BM
    JAMA; 2008 Jul; 300(2):156-7. PubMed ID: 18612108
    [No Abstract]   [Full Text] [Related]  

  • 34. Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS).
    Zhang X; Hamadeh IS; Song S; Katz J; Moreb JS; Langaee TY; Lesko LJ; Gong Y
    J Bone Miner Res; 2016 Feb; 31(2):336-40. PubMed ID: 26288087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Information-Derived Mechanistic Hypotheses for Structural Cardiotoxicity.
    Svensson F; Zoufir A; Mahmoud S; Afzal AM; Smit I; Giblin KA; Clements PJ; Mettetal JT; Pointon A; Harvey JS; Greene N; Williams RV; Bender A
    Chem Res Toxicol; 2018 Nov; 31(11):1119-1127. PubMed ID: 30350600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA's sentinel network: a monumental task.
    Young D
    Am J Health Syst Pharm; 2007 Apr; 64(8):800-1. PubMed ID: 17420189
    [No Abstract]   [Full Text] [Related]  

  • 37. Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.
    de Bie S; Ferrajolo C; Straus SM; Verhamme KM; Bonhoeffer J; Wong IC; Sturkenboom MC;
    PLoS One; 2015; 10(6):e0130399. PubMed ID: 26090678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs associated with serum sickness and serum sickness-like reactions: A review of FDA Adverse Event Reporting System (FAERS) data.
    Surdacki M; Fernandez E; Phillips EJ; Stone CA
    J Allergy Clin Immunol Pract; 2024 May; 12(5):1351-1354.e1. PubMed ID: 38462072
    [No Abstract]   [Full Text] [Related]  

  • 39. Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS.
    Fujimoto M; Hosomi K; Takada M
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):259-66. PubMed ID: 24472404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
    Alatawi YM; Hansen RA
    Expert Opin Drug Saf; 2017 Jul; 16(7):761-767. PubMed ID: 28447485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.